US Patent Issued to Julius-Maximilians-Universitat Wurzburg on March 17 for "Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase" (German Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,138, issued on March 17, was assigned to Julius-Maximilians-Universitat Wurzburg (Wurzburg, Germany).

"Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase" was invented by Lorenz Meinel (Wurzburg, Germany), Tessa Luhmann (Wurzburg, Germany) and Alexandra Braun (Gerbrunn, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and their use in the treatment of lesions, in tissue regeneration and/or tissue engineering. The compounds act as substrates for enzymes having transglutaminase activity and are suitable for their immobilization and/or at...